BRAIN Biotech AG (BNN) — Cash Flow Reinvestment Rate
Latest as of June 2024:
2.58x
BRAIN Biotech AG (BNN) has a Cash Flow Reinvestment Rate of 2.58x as of June 2024, reinvesting €1.33 Million (capex €720.00K plus investments €-609.00K) from operating cash flow of €516.00K. Check BRAIN Biotech AG cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
2.58x
(Capex + Investments) / Operating CF
Total Reinvested
€1.33 Million
Capex + Investments
Operating Cash Flow
€516.00K
EUR
Capital Expenditures
€720.00K
EUR
Annual Cash Flow Reinvestment Rate for BRAIN Biotech AG (None–None)
Year-by-year capital reinvestment analysis for BRAIN Biotech AG. For live market cap and broader valuation context, see BNN stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow